These reagents are being developed both in preclinical models and in the clinic in Southampton. Professor Glennie is an adjunct...
regulating
This opens up the possibility of refining agonistic activity by engineering reagents which bind with the correct affinity to this...
Immunostimulatory monoclonal antibodies became newsworthy when the drug ipilimumab proved effective against metastatic melanoma and was approved for patients by...
